Risk factors for progressive disease after immune checkpoint inhibitors (ICIs) in advanced head and neck squamous cell carcinoma (HNSCC): Who might not be candidate for ICI?

Jang, S. Y.; Lee, Y-G.; Chun, S. H.; Park, J. H.; Park, K. U.; Chang, H.; Lee, K-W.; Kim, H. R.; Shin, S-H.; An, H. J.; Lee, K-E.; Hwang, I. G.; Ahn, M-J.; Kim, S-B.; Keam, B.

doi:10.1016/j.annonc.2023.09.2085

Detailed Information

Cited 0 time in webofscience

Cited 0 time in scopus

Metadata Downloads

Risk factors for progressive disease after immune checkpoint inhibitors (ICIs) in advanced head and neck squamous cell carcinoma (HNSCC): Who might not be candidate for ICI?open access

Authors: Jang, S. Y.; Lee, Y-G.; Chun, S. H.; Park, J. H.; Park, K. U.; Chang, H.; Lee, K-W.; Kim, H. R.; Shin, S-H.; An, H. J.; Lee, K-E.; Hwang, I. G.; Ahn, M-J.; Kim, S-B.; Keam, B.

Issue Date: Oct-2023

Publisher: ELSEVIER

Citation: ANNALS OF ONCOLOGY, v.34, pp S591 - S591

Journal Title: ANNALS OF ONCOLOGY

Volume: 34

Start Page: S591

End Page: S591

URI: https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/71307

DOI: 10.1016/j.annonc.2023.09.2085

ISSN: 0923-7534
1569-8041

Files in This Item: There are no files associated with this item.

Appears in Collections: ETC > 1. Journal Articles

Show full item record

qrcode

Related Researcher

Researcher Hwang, In Gyu photo

Hwang, In Gyu: 의과대학 (의학부(임상-서울))

Read more

Altmetrics

Total Views & Downloads

STATISTICS: Total View :7,449,026; Today View :8,649

RSS_1.0 RSS_2.0 ATOM_1.0

84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Related Researcher

Altmetrics

Total Views & Downloads

BROWSE